Page last updated: 2024-08-21

3',5'-dichloromethotrexate and Leukemia

3',5'-dichloromethotrexate has been researched along with Leukemia in 2 studies

*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GOLDIN, A; KLINE, I; MEAD, JA; SCHRECKER, AW; VENDITTI, JM1
GOLDIN, A; HUMPHREYS, SR1

Other Studies

2 other study(ies) available for 3',5'-dichloromethotrexate and Leukemia

ArticleYear
Influence of the route of administration on the relative effectiveness of 3',5'-dichloroamethopterin and amethopterin against advanced leukemia (L1210) in mice.
    Cancer research, 1960, Volume: 20

    Topics: Animals; Antineoplastic Agents; Folic Acid Antagonists; Leukemia; Leukemia, Experimental; Methotrexate; Mice

1960
Investigation of tumor variants recovered from mice with systemic leukemia (L1210) after extensive therapy with 3',5'-dichloroamethopterin and 3'-bromo-5'-chloroamethopterin.
    Journal of the National Cancer Institute, 1959, Volume: 23

    Topics: Animals; Folic Acid Antagonists; Leukemia; Leukemia, Experimental; Methotrexate; Mice

1959